Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: Formoterol in Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating formoterol for diabetic nephropathy and diabetic kidney disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Formoterol (formoterol)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Diabetic Nephropathies, Diabetic Kidney Disease | Phase 2 | Status: RECRUITING